Quantcast

BioFactura gets federal contract to develop smallpox drug

A Frederick maker of biodefense countermeasures has received a contract worth up to $67.4 million for development of a smallpox drug.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.